133 related articles for article (PubMed ID: 9473858)
1. Assessment of mutations of Ha- and Ki-ras oncogenes and the p53 suppressor gene in seven malignant mesothelioma patients exposed to asbestos--PCR-SSCP and sequencing analyses of paraffin-embedded primary tumors.
Kitamura F; Araki S; Tanigawa T; Miura H; Akabane H; Iwasaki R
Ind Health; 1998 Jan; 36(1):52-6. PubMed ID: 9473858
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients.
Kitamura F; Araki S; Suzuki Y; Yokoyama K; Tanigawa T; Iwasaki R
Ind Health; 2002 Apr; 40(2):175-81. PubMed ID: 12064559
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos.
Ni Z; Liu Y; Keshava N; Zhou G; Whong W; Ong T
Mutat Res; 2000 Jun; 468(1):87-92. PubMed ID: 10863160
[TBL] [Abstract][Full Text] [Related]
4. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations in asbestos associated cancers.
Liu BC; Fu DC; Miao Q; Wang HH; You BR
Biomed Environ Sci; 1998 Sep; 11(3):226-32. PubMed ID: 9861481
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.
Vähäkangas KH; Samet JM; Metcalf RA; Welsh JA; Bennett WP; Lane DP; Harris CC
Lancet; 1992 Mar; 339(8793):576-80. PubMed ID: 1347094
[TBL] [Abstract][Full Text] [Related]
7. Sporadic p53 mutations and absence of ras mutations in glioblastomas.
Gömöri E; Dóczi T; Pajor L; Matolcsy A
Acta Neurochir (Wien); 1999; 141(6):593-9. PubMed ID: 10929724
[TBL] [Abstract][Full Text] [Related]
8. [PCR-SSCP and sequencing analysis on mutations of anti-oncogene p53 in asbestos-related lung cancer].
Fu D; Liu B; Miao Q; Wang H
Wei Sheng Yan Jiu; 1997 Sep; 26(5):289-92. PubMed ID: 10325638
[TBL] [Abstract][Full Text] [Related]
9. Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas.
Mayall FG; Jacobson G; Wilkins R
J Clin Pathol; 1999 Apr; 52(4):291-3. PubMed ID: 10474522
[TBL] [Abstract][Full Text] [Related]
10. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
11. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
12. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
13. p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Metcalf RA; Welsh JA; Bennett WP; Seddon MB; Lehman TA; Pelin K; Linnainmaa K; Tammilehto L; Mattson K; Gerwin BI
Cancer Res; 1992 May; 52(9):2610-5. PubMed ID: 1568228
[TBL] [Abstract][Full Text] [Related]
14. [K-ras gene mutations of asbestos and welding-fumes related human lung cancer].
Huang B; Liu B; Xu M; You B
Wei Sheng Yan Jiu; 2000 Jan; 29(1):7-9. PubMed ID: 12725029
[TBL] [Abstract][Full Text] [Related]
15. Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers.
Ewis AA; Kondo K; Lee J; Tsuyuguchi M; Hashimoto M; Yokose T; Mukai K; Kodama T; Shinka T; Monden Y; Nakahori Y
Am J Ind Med; 2001 Jul; 40(1):92-7. PubMed ID: 11439401
[TBL] [Abstract][Full Text] [Related]
16. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
18. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.
Mäki-Nevala S; Sarhadi VK; Knuuttila A; Scheinin I; Ellonen P; Lagström S; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuutila S
Lung; 2016 Feb; 194(1):125-35. PubMed ID: 26463840
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
20. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
